Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N3PC
|
|||
| Former ID |
DIB010434
|
|||
| Drug Name |
MR1-1
|
|||
| Synonyms |
MR1-1KDEL; EGFR-specific immunotoxin, IVAX; Anticancer immunotoxin (EGFR-specific), IVAX
Click to Show/Hide
|
|||
| Indication | Brain cancer [ICD-11: 2A00] | Phase 1 | [1] | |
| Company |
IVAX Corp
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01009866) Study of Immunotoxin, MR1-1. U.S. National Institutes of Health. | |||
| REF 2 | A Phase I Study of Immunotoxin, MR1-1. Duke University report. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.